COT Meeting: 10th December 2024

This page is currently being edited. 

Meeting Agenda

1.    Apologies for absence.

2.     Draft minutes and reserved minutes of the 21st October 2024 meeting TOX/MIN/2024/06.

3.    Matters arising.         

4.    Authorisation of the substance Glycolipids (E 246) (Nagardo, AM-1) for use as a new food additive. (RP1457) (Reserved) TOX/2024/41. 

5.    Extension of use of nisin (E 234) to a new food category “egg analogues” (RP42) (Reserved) TOX/2024/422. 

6.   Echinacea in the maternal diet TOX/2024/43.         

7.   Third Draft Statement on the Safety of Ginger Supplement Use in Pregnancy TOX/2024/44.

8.   Discussion paper on the effects of calcidiol supplementation during pregnancy TOX/2024/45. 

9.   Developing COT guidance TOX/2024/46.

10. Update on the work of other FSA Scientific Advisory Committees - for information  TOX/2024/47. 

11.  Any other business.

Next meeting of the Committee – Tuesday 4th February 2025  via Teams.

Matters arising:

• JEG Updates

Media discussed during the meeting

TOX/MIN/2024/06

Draft Minutes of the 21st October 2024 COT Meeting

TOX/2024/41

(Reserved)

TOX/2024/42

(Reserved)

TOX/2024/43

Discussion paper on the potential health effects of Echinacea in the maternal diet

TOX/2024/44

Third Draft Statement on the Safety of Ginger Supplement use in Pregnancy

Third Draft Statement on the Safety of Ginger Supplement Use in Pregnancy - Annex A

Safety of Ginger Supplement Use in Pregnancy - Annex B

Safety of Ginger Supplement Use in Pregnancy - Annex C Assessment of Exposure

Safety of Ginger Supplement Use in Pregnancy - Annex C

TOX/2024/45

Discussion paper on the effects of Calcidiol supplementation during pregnancy

TOX/2024/46

Developing COT guidance

TOX/2024/47

Update on the work of other Scientific Advisory Committees-December 2024